Posts Tagged: trial

Impact of radiotherapy when added to androgen-deprivation therapy for locally advanced prostate cancer

The NCIC CTG PR3/MRC PR07 randomized phase III trial compared androgen-deprivation therapy (ADT) alone versus ADT with radiotherapy (RT) for patients with locally advanced prostate cancer. The addition of RT to ADT for patients with locally advanced prostate cancer significantly improved overall survival and had only modest and transient negative impact on relevant domains of… Read more »

The FORECAST Study – Focal Recurrent Assessment and Salvage Treatment for Radiorecurrent Prostate Cancer

One-third of men may experience biochemical failure by 8years following radical radiotherapy for localised prostate cancer. Over 90% of men are started on androgen deprivation therapy (ADT) which is non-curative and confers systemic side-effects. Focal salvage therapy (FST) limits collateral tissue damage and may improve therapeutic ratios. In order to deliver FST, distant disease must… Read more »

More North-East lung cancer patients to get access to cutting edge treatment as part of clinical trial

A cutting edge radiotherapy treatment is to be offered to early stage lung cancer patients as part of a clinical trial taking place in the region. Patients from Middlesbrough will be recruited for the £240,000 trial, which will use stereotactic ablative radiotherapy to treat the cancer over three to eight treatments. The Northern Echo

Nanobiotix gets green light for liver cancer trial

Nanobiotix, the developer of nano-medical technology, has been given clearance to start a new clinical trial for its lead NanoXray product, NBTXR3. The test will evaluate the use of NBTXR3 in conjunction with high precision radiation therapy, delivered as high dose fractions, known as Stereotatic Body Radiotherapy. Proactive Investors

Cutting edge radiotherapy treatment to benefit Gwent patients

Patients from Gwent are set to be among more than 300 a year from Wales who will benefit from a cutting-edge radiotherapy technique now being provided at Velindre Cancer Centre in Cardiff. The centre has begun using stereotactic radiosurgery, meaning patients who previously had to travel to Sheffield to benefit from it, can now receive… Read more »

Barts Health NHS Trust has been selected to offer its cancer patients SABR

Cancer patients being treated by Barts Health Trust could be among the first to be treated with an ‘innovative’ form of radiotherapy treatment. NHS England announced earlier this week that Barts has been chosen as one of the trusts treat patients with stereotactic ablative radiotherapy (SABR), as part their latest national evaluation programme. East London… Read more »

750 cancer patients’ hope

Sheffield Teaching Hospital has become one of the first centres in the country to be provided with new cutting-edge radiotherapy machines. The NHS has invested £15m over three years to assess the use of stereotactic ablative radiotherapy (SABR) – in a move it’s hoped could save hundreds of lives. The Star

Radiation experts unite to streamline cancer clinical trials

Regulations on radiation exposure have been a critical bottleneck in starting up new cancer trials, but now radiation experts from the Experimental Cancer Medicine Centre (link is external)(ECMC) network – a joint initiative between Cancer Research UK and the UK’s four health departments – are pioneering a new streamlined system to reduce the time taken… Read more »